Skip to main content
Caplight Logo









NanoPalm

NanoPalm

Private
RiyadhHealthcare & Life Scienceshttps://nanopalm.ltd/

Last Round

Accelerator

Jun 19, 2025

Company Overview

NanoPalm operates in Healthcare & Life Sciences and is based in Riyadh. Its latest recorded funding round was an Accelerator round in June 2025.

NanoPalm is a biotechnology company that develops AI-designed patterned lipid nanoparticle (pLNP) delivery systems for gene and drug therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Infrastructure

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

NanoPalm Comparables

Compare NanoPalm with similar companies based on industry and business-model similarity.

NanoPalm comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Mana.bio
88%
Liberate Bio
80%
Entos Pharmaceuticals
76%
Book a demo to see all comparables

For institutional investors. Book with your work email.

NanoPalm Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJun 19, 2025
AcceleratorApr 29, 2025
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Samar Alsudir

Co-Founder CTO

Founding Team

Ali H. AlHasan

Founder & CEO

Founding Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 2, 2025

    Grew 183% QoQ, from 6 to 17 employees.

  • Jul 29, 2025

    Grew 260% QoQ, from 5 to 18 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

NanoPalm Filings

Explore SEC and related filing metadata, where available.

NanoPalm filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about NanoPalm's valuation, stock price, and market status.

Is NanoPalm a public or private company?

NanoPalm is a private company.

What is the current stock price of NanoPalm?

NanoPalm is a private company, so its shares have no public market price. Caplight tracks NanoPalm's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is NanoPalm worth (valuation)?

Valuation information for NanoPalm is not publicly available.

Can I buy NanoPalm stock?

NanoPalm shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was NanoPalm's last funding round?

NanoPalm's most recent funding round was Accelerator on June 19, 2025.

Who are the main investors in NanoPalm?

Investor information for NanoPalm is not publicly disclosed.

Will NanoPalm IPO soon?

No public IPO plans have been announced for NanoPalm.

How can I track NanoPalm secondary market activity?

Caplight tracks bids, offers, and trades in NanoPalm's shares on secondary markets.

Firmographic Details

HeadquartersRiyadh
Employee Range11
Year Founded2022
Last FundingJun 19, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?